Pre-exposure prophylaxis with tixagevimab and cilgavimab (Evusheld) for COVID-19 among 1112 severely immunocompromised patients
Yann Nguyen, Adrien Flahault, Nathalie Chavarot, Cléa Melenotte, Morgane Cheminant, P Deschamps, Nicolas Carlier, Emmanuel Lafont, M. Thomas, Edouard Flamarion, David Lebeaux, Caroline Charlier, A. Rachline, Corinne Guérin, Robert Ratiney, J Touchard, Hélène Péré, Flore Rozenberg, Fanny Lanternier, Jean‐Benoît Arlet, Jérôme Avouac, Véronique Boussaud, R. Guillemain, Marguerite Vignon, Éric Thervet, Anne Scemla, Laurence Weiss, Luc Mouthon
Topics & Concepts
MedicineIncidence (geometry)Coronavirus disease 2019 (COVID-19)Internal medicineSevere acute respiratory syndrome coronavirus 2 (SARS-CoV-2)CohortObservational studyCohort studyRetrospective cohort studyPediatricsOpticsPhysicsInfectious disease (medical specialty)DiseaseSARS-CoV-2 and COVID-19 ResearchCOVID-19 Clinical Research StudiesImmune responses and vaccinations